BlackRock Fund Advisors’s Evolent Health EVH Stock Holding History

BlackRock Fund Advisors’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7.33M	Buy	494,932 +103,257	+26%	+$2.03M	﹤0.01%	2749
2016 Q3	$9.64M	Buy	391,675 +32,608	+9%	+$762K	﹤0.01%	2494
2016 Q2	$6.89M	Buy	359,067 +47,715	+15%	+$655K	﹤0.01%	2622
2016 Q1	$3.29M	Sell	311,352 -15,710	-5%	-$162K	﹤0.01%	2933
2015 Q4	$3.96M	Buy	327,062 +12,970	+4%	+$191K	﹤0.01%	2948
2015 Q3	$5.01M	Buy	+314,092	New	+$6.13M	﹤0.01%	2806

Other funds holding EVH

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

BlackRock Fund Advisors's EVH Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Evolent Health (EVH) stake by 26% in Q4 2016, buying an estimated $2.03M and bringing the position to 494,932 shares worth $7.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2749.

BlackRock Fund Advisors first reported a position in EVH in Q3 2015 and has held it in 6 quarters since. The position peaked at $9.64M in Q3 2016. 118 funds tracked by Wall St. Rank hold EVH as of Q4 2016.

BlackRock Fund Advisors held 494,932 shares of Evolent Health worth $7.33M as of Q4 2016.
BlackRock Fund Advisors bought 103,257 Evolent Health shares in Q4 2016, an estimated $2.03M.
Evolent Health made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2749 holding.
BlackRock Fund Advisors first reported a position in Evolent Health in Q3 2015 and has held it in 6 quarters since.
BlackRock Fund Advisors's Evolent Health position peaked at $9.64M in Q3 2016.
118 funds tracked by Wall St. Rank held Evolent Health as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.